Quick Takeaways
- This page summarizes Avi Pelossof's Form 4 filing for NEOGEN CORP (NEOG).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 28 Oct 2025, 08:51.
Avi Pelossof - 24 Oct 2025 Form 4 Insider Report for NEOGEN CORP (NEOG)
- Role
- Director
- Signature
- Christopher Sefcheck (Attorney in Fact)
- Issuer symbol
- NEOG
- Transactions as of
- 24 Oct 2025
- Net transactions value
- +$119,999
- Form type
- 4
- Filing time
- 28 Oct 2025, 08:51:33 UTC
- SEC
- View on sec.gov
Quoteable Key Fact
"Avi Pelossof filed Form 4 for NEOGEN CORP (NEOG) on 28 Oct 2025."
What Changed
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$119,999.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Pelossof Avi | Director | 620 LESHER PLACE, LANSING | Christopher Sefcheck (Attorney in Fact) | 28 Oct 2025 | 0001293460 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NEOG | Common Stock | Award | $119,999 | +19,386 | $6.19 | 19,386 | 24 Oct 2025 | Direct | F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NEOG | Common Stock (Right to Buy) | Award | $0 | +49,929 | $0.000000 | 49,929 | 24 Oct 2025 | Common Stock | 49,929 | $6.19 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants |